BRIEF published on 08/05/2024 at 07:05, 1 year 9 months ago Relief Therapeutics obtient jusqu'à 11 millions de dollars grâce aux ventes de redevances Développement Clinique Financement Non Dilutif Approbation De La FDA Thérapeutique De Soulagement Ventes De Redevances
PRESS RELEASE published on 08/05/2024 at 07:00, 1 year 9 months ago Relief Therapeutics Secures up to $11 Million from Royalty Sales Relief Therapeutics secures $11 million from royalty sales for RLF-TD011 clinical development and pipeline advancement. Funding from SWK Holdings Corporation to support rare disease treatment options SWK Holdings Corporation Clinical Development Relief Therapeutics Rare Diseases Royalty Sales
BRIEF published on 06/27/2024 at 12:50, 1 year 10 months ago Relief Therapeutics Holding SA publie les résultats de son assemblée générale annuelle Actionnaires Conseil D'administration États Financiers Résultats De L'AGA Thérapeutique De Soulagement
BRIEF published on 06/27/2024 at 12:50, 1 year 10 months ago Relief Therapeutics Holding SA Reports Results of Annual General Meeting Board Of Directors Shareholders Financial Statements Relief Therapeutics AGM Results
PRESS RELEASE published on 06/27/2024 at 12:45, 1 year 10 months ago RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting RELIEF THERAPEUTICS Holding SA announces the results of its Annual General Meeting of Shareholders in Geneva. Details on approved resolutions and election outcomes Annual General Meeting Shareholders Resolutions RELIEF THERAPEUTICS Holding SA Geneva
BRIEF published on 06/03/2024 at 07:05, 1 year 11 months ago Relief Therapeutics Announces Executive Changes Board Of Directors Executive Changes Biopharmaceutical Relief Therapeutics Senior Management
BRIEF published on 06/03/2024 at 07:05, 1 year 11 months ago Relief Therapeutics annonce des changements à la direction Conseil D'administration Biopharmaceutique Changements De Direction Thérapeutique De Soulagement La Haute Direction
PRESS RELEASE published on 06/03/2024 at 07:00, 1 year 11 months ago Relief Therapeutics Announces Executive Changes Relief Therapeutics announces executive changes as interim CEO Michelle Lock completes her mandate and transitions out, along with other key executives. Board to review management for optimal results Executive Changes Biopharmaceutical Relief Therapeutics Rare Diseases Management Review
BRIEF published on 05/30/2024 at 07:05, 1 year 11 months ago Relief Therapeutics annonce l'avis de convocation à l'assemblée générale annuelle des actionnaires Biopharmaceutique AGA 2024 Thérapeutique De Soulagement Rencontre D'actionnaires Genève
BRIEF published on 05/30/2024 at 07:05, 1 year 11 months ago Relief Therapeutics Announces Notice of Annual General Meeting of Shareholders Biopharmaceutical Relief Therapeutics AGM 2024 Shareholders Meeting Geneva
Published on 05/08/2026 at 01:50, 6 hours 12 minutes ago Apex Critical Metals Announces Grant of Stock Options and RSUs
Published on 05/08/2026 at 00:45, 7 hours 17 minutes ago Route1 Announces First Quarter 2026 Financial Results Notification
Published on 05/08/2026 at 00:00, 8 hours 2 minutes ago Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 8 hours 32 minutes ago Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 8 hours 47 minutes ago BULGOLD Adopts Semi-Annual Financial Reporting
Published on 05/08/2026 at 07:58, 4 minutes ago Commerzbank delivers strong first quarter and targets Net RoTE of 21% by 2030
Published on 05/08/2026 at 07:55, 6 minutes ago AUSTRIAN POST IN Q1 2026: Slight first-quarter revenue improvement despite a challenging market environment, earnings below the previous year as expected
Published on 05/08/2026 at 07:30, 32 minutes ago Bechtle achieves double-digit growth in business volume and earnings
Published on 05/08/2026 at 07:30, 32 minutes ago Pyrum Innovations AG publishes figures for the 2025 financial year
Published on 05/07/2026 at 19:15, 12 hours 47 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 12 hours 47 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 12 hours 56 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 12 hours 56 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 13 hours 2 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
